自動注射器市場：成分、タイプ、投与方法、流通チャネル、治療用途、最終用途別-2025-2030年世界予測

自動注射器市場は、2024年に10億1,000万米ドルと評価され、2025年には11億米ドル、CAGR 9.22%で成長し、2030年には17億2,000万米ドルに達すると予測されています。

自動注射器は現代のヘルスケアにおいて極めて重要な技術として登場し、薬剤の投与を正確、安全、効率的に変革しています。本エグゼクティブサマリーでは、自動注射器の進化と、様々な治療分野におけるその重要性の高まりについて考察します。近年、デバイス工学とバイオテクノロジーの急速な進歩により、自動注射器は単純な送達機構から、患者のコンプライアンス向上と臨床転帰の改善を確実にする洗練されたツールへと昇華しました。技術革新は、迅速で使いやすい薬剤投与に対する需要の高まりと相まって、これらの機器の開発と普及の両面で成長を促しています。

このようなダイナミックな状況の中、メーカーは使いやすさと信頼性を高める機能を統合することで革新を続け、救急医療と慢性期医療の両方の場面で利用可能な治療選択肢の幅を広げています。市場は、こうした技術的進歩から恩恵を受けるだけでなく、安全プロトコルとコスト効率への関心の高まりからも恩恵を受ける。臨床、製造、規制の各分野の利害関係者が自動注射器市場に集結するにつれ、業界は生産基準、流通戦略、エンドユーザー統合において大きな変化を目の当たりにしています。

この包括的な概要は、自動注射器領域の成長を促進する変革的動向と微妙な市場力学の両方を理解しようとする意思決定者や専門家にとって不可欠な洞察を提供します。

情勢の変化：変化と革新の受け入れ

近年、自動注射器市場は、技術の飛躍的進歩、進化する患者のニーズ、ダイナミックな規制環境に牽引され、変革的なシフトを経験しています。メーカーは、デバイスの耐久性を高めるだけでなく、ユーザーエクスペリエンスを大幅に向上させる最先端の素材や設計手法を採用しています。ヘルスケアのエコシステムがより患者中心になるにつれ、自動注射器は、緊急時や日常的な治療において、迅速かつ信頼性が高く、直感的な結果を提供するよう設計されるようになってきています。

市場のリーダーたちはデジタル統合を活用し、リアルタイムのモニタリング、データ分析、より広範な健康管理システムとの接続を可能にするスマート機能を組み込んでいます。この進化は、特に安全プロトコルの改善と正確な投与メカニズムにおいて顕著であり、臨床医とエンドユーザーの双方から支持を集めています。同時に、規制機関も製品の安全性を確保しながら技術革新を促すような、より厳格な基準を設けつつあり、高品質の次世代自動注射器が活躍できる環境を整えつつあります。

このようなシフトは、患者が個別化された利用しやすいケアを求めるヘルスケア提供の分散化に重点が置かれるようになっていることに後押しされています。高度なセンサー技術と人間工学に基づいた設計原則の融合は、機器の性能向上を推進し続けています。従来の治療モデルが進化する中、自動注射器の適応性と拡張性は最新の治療パラダイムの最前線に位置し、最終的に患者の関与と転帰を変革します。

主要セグメントに関する洞察自動注射器市場の多様な構成要素を理解する

自動注射器市場を詳細に調査すると、いくつかの重要な次元にまたがる重要なセグメンテーションが明らかになり、それぞれが業界全体の成長とイノベーションに独自に寄与しています。構成要素に基づく洞察に満ちた分析では、市場が起動ボタン、注射針、ペンキャップ、プレロードスプリング、一次薬剤容器にわたって綿密に調査されていることが示されています。このアプローチにより、製品の機械的な複雑さと、強化された性能と安全対策に対応するための進化を詳しく調べることができます。

さらに製品タイプに基づくセグメンテーションを行い、使い捨てと再利用可能な器具を区別することで、消費者の嗜好とライフサイクル管理に光を当てることができます。この区別は、この分野における価格戦略や持続可能性の検討において重要な役割を果たしています。さらに、投与方法（特に筋肉内投与と皮下投与）による区分は、自動注射器の治療適応性に関する重要な洞察を提供し、デバイスの機能を臨床要件に合致させる。

流通チャネルもセグメンテーション分析に役立ち、オフライン小売とオンライン小売の枠組みは、消費者行動と市場アクセスのシフトを浮き彫りにします。治療用途が認識された場合、市場は慢性治療、緊急治療、予防治療の各セグメントに分けられ、それぞれに独自の規制や製剤アプローチが求められます。最後に、最終用途に基づく評価では、在宅医療環境と病院・診療所を区別し、これらの機器の配備と管理を規定する運用の多様性を強調します。これらのセグメンテーションを総合すると、市場動向をきめ細かく理解することができ、製品ポートフォリオと市場参入の最適化を目指す利害関係者の戦略的意思決定を支援することができます。

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 慢性疾患および生活習慣病の世界の蔓延
    • 在宅および緊急治療ソリューションの需要増加
  • 抑制要因
    • 厳格な規制遵守と長い承認プロセス
  • 機会
    • 個別化治療アプローチのための統合データ分析を備えた自動注射器の開発
    • スポーツ医学と緊急対応のシナリオにおける自動注射器の採用拡大
  • 課題
    • 自動注射器の廃棄に関する環境懸念
• 市場セグメンテーション分析
  • タイプ：救急医療および急性期医療の現場で使い捨て自動注射器が好まれる傾向
  • 治療用途：救急治療における自動注射器の利用拡大
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社会
  • 技術的
  • 法律上
  • 環境

第6章 自動注射器市場：コンポーネント別

• アクティベーションボタン
• 針
• ペンキャップ
• プリロードスプリング
• 主な薬剤容器

第7章 自動注射器市場：タイプ別

• 使い捨て
• 再利用可能

第8章 自動注射器市場投与方法別

• 筋肉内
• 皮下

第9章 自動注射器市場：流通チャネル別

• オフライン小売
• オンライン小売

第10章 自動注射器市場治療用途別

• 慢性治療
• 緊急治療
• 予防治療

第11章 自動注射器市場：最終用途別

• 在宅ケア設定
• 病院と診療所

第12章 南北アメリカの自動注射器市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第13章 アジア太平洋地域の自動注射器市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第14章 欧州・中東・アフリカの自動注射器市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第15章 競合情勢

• 市場シェア分析, 2024
• FPNVポジショニングマトリックス, 2024
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• AbbVie Inc.
• Aktiv Medical Systems
• Amgen Inc.
• Amneal Pharmaceuticals, Inc.
• AptarGroup, Inc.
• Bayer AG
• Becton, Dickinson and Company
• Biogen Inc.
• Eli Lilly and Company
• Gerresheimer AG
• GlaxoSmithKline PLC
• Halozyme Therapeutics, Inc.
• Johnson & Johnson Services, Inc.
• Medeca Pharma AB
• Merck KGaA
• Mylan N.V. by Viatris Inc.
• NEMERA Group
• Novartis AG
• Pfizer, Inc.
• Ravimed Sp. z o.o.
• Recipharm AB
• Sanofi S.A.
• SHL Medical AG
• Stevanato Group
• Teva Pharmaceutical Industries Ltd.
• West Pharmaceutical Services, Inc.
• Ypsomed Holding AG

LIST OF FIGURES

• FIGURE 1. AUTO-INJECTORS MARKET MULTI-CURRENCY
• FIGURE 2. AUTO-INJECTORS MARKET MULTI-LANGUAGE
• FIGURE 3. AUTO-INJECTORS MARKET RESEARCH PROCESS
• FIGURE 4. AUTO-INJECTORS MARKET SIZE, 2024 VS 2030
• FIGURE 5. GLOBAL AUTO-INJECTORS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 6. GLOBAL AUTO-INJECTORS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 7. GLOBAL AUTO-INJECTORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL AUTO-INJECTORS MARKET SIZE, BY COMPONENT, 2024 VS 2030 (%)
• FIGURE 9. GLOBAL AUTO-INJECTORS MARKET SIZE, BY COMPONENT, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL AUTO-INJECTORS MARKET SIZE, BY TYPE, 2024 VS 2030 (%)
• FIGURE 11. GLOBAL AUTO-INJECTORS MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL AUTO-INJECTORS MARKET SIZE, BY MODE OF ADMINISTRATION, 2024 VS 2030 (%)
• FIGURE 13. GLOBAL AUTO-INJECTORS MARKET SIZE, BY MODE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 14. GLOBAL AUTO-INJECTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
• FIGURE 15. GLOBAL AUTO-INJECTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 16. GLOBAL AUTO-INJECTORS MARKET SIZE, BY THERAPEUTIC USE, 2024 VS 2030 (%)
• FIGURE 17. GLOBAL AUTO-INJECTORS MARKET SIZE, BY THERAPEUTIC USE, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 18. GLOBAL AUTO-INJECTORS MARKET SIZE, BY END USE, 2024 VS 2030 (%)
• FIGURE 19. GLOBAL AUTO-INJECTORS MARKET SIZE, BY END USE, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 20. AMERICAS AUTO-INJECTORS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 21. AMERICAS AUTO-INJECTORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 22. UNITED STATES AUTO-INJECTORS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
• FIGURE 23. UNITED STATES AUTO-INJECTORS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 24. ASIA-PACIFIC AUTO-INJECTORS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 25. ASIA-PACIFIC AUTO-INJECTORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 26. EUROPE, MIDDLE EAST & AFRICA AUTO-INJECTORS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 27. EUROPE, MIDDLE EAST & AFRICA AUTO-INJECTORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 28. AUTO-INJECTORS MARKET SHARE, BY KEY PLAYER, 2024
• FIGURE 29. AUTO-INJECTORS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

• TABLE 1. AUTO-INJECTORS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
• TABLE 3. GLOBAL AUTO-INJECTORS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL AUTO-INJECTORS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL AUTO-INJECTORS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. AUTO-INJECTORS MARKET DYNAMICS
• TABLE 7. GLOBAL AUTO-INJECTORS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL AUTO-INJECTORS MARKET SIZE, BY ACTIVATION BUTTON, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL AUTO-INJECTORS MARKET SIZE, BY NEEDLE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL AUTO-INJECTORS MARKET SIZE, BY PEN CAP, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL AUTO-INJECTORS MARKET SIZE, BY PRE-LOADED SPRING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL AUTO-INJECTORS MARKET SIZE, BY PRIMARY DRUG CONTAINER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL AUTO-INJECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL AUTO-INJECTORS MARKET SIZE, BY DISPOSABLE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL AUTO-INJECTORS MARKET SIZE, BY REUSABLE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL AUTO-INJECTORS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL AUTO-INJECTORS MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL AUTO-INJECTORS MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL AUTO-INJECTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL AUTO-INJECTORS MARKET SIZE, BY OFFLINE RETAIL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL AUTO-INJECTORS MARKET SIZE, BY ONLINE RETAIL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL AUTO-INJECTORS MARKET SIZE, BY THERAPEUTIC USE, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL AUTO-INJECTORS MARKET SIZE, BY CHRONIC TREATMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL AUTO-INJECTORS MARKET SIZE, BY EMERGENCY TREATMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL AUTO-INJECTORS MARKET SIZE, BY PREVENTIVE TREATMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL AUTO-INJECTORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL AUTO-INJECTORS MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL AUTO-INJECTORS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. AMERICAS AUTO-INJECTORS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 30. AMERICAS AUTO-INJECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 31. AMERICAS AUTO-INJECTORS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 32. AMERICAS AUTO-INJECTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 33. AMERICAS AUTO-INJECTORS MARKET SIZE, BY THERAPEUTIC USE, 2018-2030 (USD MILLION)
• TABLE 34. AMERICAS AUTO-INJECTORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 35. AMERICAS AUTO-INJECTORS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 36. ARGENTINA AUTO-INJECTORS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 37. ARGENTINA AUTO-INJECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 38. ARGENTINA AUTO-INJECTORS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 39. ARGENTINA AUTO-INJECTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 40. ARGENTINA AUTO-INJECTORS MARKET SIZE, BY THERAPEUTIC USE, 2018-2030 (USD MILLION)
• TABLE 41. ARGENTINA AUTO-INJECTORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 42. BRAZIL AUTO-INJECTORS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 43. BRAZIL AUTO-INJECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 44. BRAZIL AUTO-INJECTORS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 45. BRAZIL AUTO-INJECTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 46. BRAZIL AUTO-INJECTORS MARKET SIZE, BY THERAPEUTIC USE, 2018-2030 (USD MILLION)
• TABLE 47. BRAZIL AUTO-INJECTORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 48. CANADA AUTO-INJECTORS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 49. CANADA AUTO-INJECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 50. CANADA AUTO-INJECTORS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 51. CANADA AUTO-INJECTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 52. CANADA AUTO-INJECTORS MARKET SIZE, BY THERAPEUTIC USE, 2018-2030 (USD MILLION)
• TABLE 53. CANADA AUTO-INJECTORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 54. MEXICO AUTO-INJECTORS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 55. MEXICO AUTO-INJECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 56. MEXICO AUTO-INJECTORS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 57. MEXICO AUTO-INJECTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 58. MEXICO AUTO-INJECTORS MARKET SIZE, BY THERAPEUTIC USE, 2018-2030 (USD MILLION)
• TABLE 59. MEXICO AUTO-INJECTORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 60. UNITED STATES AUTO-INJECTORS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 61. UNITED STATES AUTO-INJECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 62. UNITED STATES AUTO-INJECTORS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 63. UNITED STATES AUTO-INJECTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 64. UNITED STATES AUTO-INJECTORS MARKET SIZE, BY THERAPEUTIC USE, 2018-2030 (USD MILLION)
• TABLE 65. UNITED STATES AUTO-INJECTORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 66. UNITED STATES AUTO-INJECTORS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 67. ASIA-PACIFIC AUTO-INJECTORS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 68. ASIA-PACIFIC AUTO-INJECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 69. ASIA-PACIFIC AUTO-INJECTORS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 70. ASIA-PACIFIC AUTO-INJECTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 71. ASIA-PACIFIC AUTO-INJECTORS MARKET SIZE, BY THERAPEUTIC USE, 2018-2030 (USD MILLION)
• TABLE 72. ASIA-PACIFIC AUTO-INJECTORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 73. ASIA-PACIFIC AUTO-INJECTORS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 74. AUSTRALIA AUTO-INJECTORS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 75. AUSTRALIA AUTO-INJECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 76. AUSTRALIA AUTO-INJECTORS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 77. AUSTRALIA AUTO-INJECTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 78. AUSTRALIA AUTO-INJECTORS MARKET SIZE, BY THERAPEUTIC USE, 2018-2030 (USD MILLION)
• TABLE 79. AUSTRALIA AUTO-INJECTORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 80. CHINA AUTO-INJECTORS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 81. CHINA AUTO-INJECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 82. CHINA AUTO-INJECTORS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 83. CHINA AUTO-INJECTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 84. CHINA AUTO-INJECTORS MARKET SIZE, BY THERAPEUTIC USE, 2018-2030 (USD MILLION)
• TABLE 85. CHINA AUTO-INJECTORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 86. INDIA AUTO-INJECTORS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 87. INDIA AUTO-INJECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 88. INDIA AUTO-INJECTORS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 89. INDIA AUTO-INJECTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 90. INDIA AUTO-INJECTORS MARKET SIZE, BY THERAPEUTIC USE, 2018-2030 (USD MILLION)
• TABLE 91. INDIA AUTO-INJECTORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 92. INDONESIA AUTO-INJECTORS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 93. INDONESIA AUTO-INJECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 94. INDONESIA AUTO-INJECTORS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 95. INDONESIA AUTO-INJECTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 96. INDONESIA AUTO-INJECTORS MARKET SIZE, BY THERAPEUTIC USE, 2018-2030 (USD MILLION)
• TABLE 97. INDONESIA AUTO-INJECTORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 98. JAPAN AUTO-INJECTORS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 99. JAPAN AUTO-INJECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 100. JAPAN AUTO-INJECTORS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 101. JAPAN AUTO-INJECTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 102. JAPAN AUTO-INJECTORS MARKET SIZE, BY THERAPEUTIC USE, 2018-2030 (USD MILLION)
• TABLE 103. JAPAN AUTO-INJECTORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 104. MALAYSIA AUTO-INJECTORS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 105. MALAYSIA AUTO-INJECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 106. MALAYSIA AUTO-INJECTORS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 107. MALAYSIA AUTO-INJECTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 108. MALAYSIA AUTO-INJECTORS MARKET SIZE, BY THERAPEUTIC USE, 2018-2030 (USD MILLION)
• TABLE 109. MALAYSIA AUTO-INJECTORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 110. PHILIPPINES AUTO-INJECTORS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 111. PHILIPPINES AUTO-INJECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 112. PHILIPPINES AUTO-INJECTORS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 113. PHILIPPINES AUTO-INJECTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 114. PHILIPPINES AUTO-INJECTORS MARKET SIZE, BY THERAPEUTIC USE, 2018-2030 (USD MILLION)
• TABLE 115. PHILIPPINES AUTO-INJECTORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 116. SINGAPORE AUTO-INJECTORS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 117. SINGAPORE AUTO-INJECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 118. SINGAPORE AUTO-INJECTORS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 119. SINGAPORE AUTO-INJECTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 120. SINGAPORE AUTO-INJECTORS MARKET SIZE, BY THERAPEUTIC USE, 2018-2030 (USD MILLION)
• TABLE 121. SINGAPORE AUTO-INJECTORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 122. SOUTH KOREA AUTO-INJECTORS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 123. SOUTH KOREA AUTO-INJECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 124. SOUTH KOREA AUTO-INJECTORS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 125. SOUTH KOREA AUTO-INJECTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 126. SOUTH KOREA AUTO-INJECTORS MARKET SIZE, BY THERAPEUTIC USE, 2018-2030 (USD MILLION)
• TABLE 127. SOUTH KOREA AUTO-INJECTORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 128. TAIWAN AUTO-INJECTORS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 129. TAIWAN AUTO-INJECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 130. TAIWAN AUTO-INJECTORS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 131. TAIWAN AUTO-INJECTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 132. TAIWAN AUTO-INJECTORS MARKET SIZE, BY THERAPEUTIC USE, 2018-2030 (USD MILLION)
• TABLE 133. TAIWAN AUTO-INJECTORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 134. THAILAND AUTO-INJECTORS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 135. THAILAND AUTO-INJECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 136. THAILAND AUTO-INJECTORS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 137. THAILAND AUTO-INJECTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 138. THAILAND AUTO-INJECTORS MARKET SIZE, BY THERAPEUTIC USE, 2018-2030 (USD MILLION)
• TABLE 139. THAILAND AUTO-INJECTORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 140. VIETNAM AUTO-INJECTORS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 141. VIETNAM AUTO-INJECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 142. VIETNAM AUTO-INJECTORS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 143. VIETNAM AUTO-INJECTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 144. VIETNAM AUTO-INJECTORS MARKET SIZE, BY THERAPEUTIC USE, 2018-2030 (USD MILLION)
• TABLE 145. VIETNAM AUTO-INJECTORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 146. EUROPE, MIDDLE EAST & AFRICA AUTO-INJECTORS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 147. EUROPE, MIDDLE EAST & AFRICA AUTO-INJECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 148. EUROPE, MIDDLE EAST & AFRICA AUTO-INJECTORS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 149. EUROPE, MIDDLE EAST & AFRICA AUTO-INJECTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 150. EUROPE, MIDDLE EAST & AFRICA AUTO-INJECTORS MARKET SIZE, BY THERAPEUTIC USE, 2018-2030 (USD MILLION)
• TABLE 151. EUROPE, MIDDLE EAST & AFRICA AUTO-INJECTORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 152. EUROPE, MIDDLE EAST & AFRICA AUTO-INJECTORS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 153. DENMARK AUTO-INJECTORS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 154. DENMARK AUTO-INJECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 155. DENMARK AUTO-INJECTORS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 156. DENMARK AUTO-INJECTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 157. DENMARK AUTO-INJECTORS MARKET SIZE, BY THERAPEUTIC USE, 2018-2030 (USD MILLION)
• TABLE 158. DENMARK AUTO-INJECTORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 159. EGYPT AUTO-INJECTORS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 160. EGYPT AUTO-INJECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 161. EGYPT AUTO-INJECTORS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 162. EGYPT AUTO-INJECTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 163. EGYPT AUTO-INJECTORS MARKET SIZE, BY THERAPEUTIC USE, 2018-2030 (USD MILLION)
• TABLE 164. EGYPT AUTO-INJECTORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 165. FINLAND AUTO-INJECTORS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 166. FINLAND AUTO-INJECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 167. FINLAND AUTO-INJECTORS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 168. FINLAND AUTO-INJECTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 169. FINLAND AUTO-INJECTORS MARKET SIZE, BY THERAPEUTIC USE, 2018-2030 (USD MILLION)
• TABLE 170. FINLAND AUTO-INJECTORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 171. FRANCE AUTO-INJECTORS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 172. FRANCE AUTO-INJECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 173. FRANCE AUTO-INJECTORS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 174. FRANCE AUTO-INJECTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 175. FRANCE AUTO-INJECTORS MARKET SIZE, BY THERAPEUTIC USE, 2018-2030 (USD MILLION)
• TABLE 176. FRANCE AUTO-INJECTORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 177. GERMANY AUTO-INJECTORS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 178. GERMANY AUTO-INJECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 179. GERMANY AUTO-INJECTORS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 180. GERMANY AUTO-INJECTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 181. GERMANY AUTO-INJECTORS MARKET SIZE, BY THERAPEUTIC USE, 2018-2030 (USD MILLION)
• TABLE 182. GERMANY AUTO-INJECTORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 183. ISRAEL AUTO-INJECTORS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 184. ISRAEL AUTO-INJECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 185. ISRAEL AUTO-INJECTORS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 186. ISRAEL AUTO-INJECTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 187. ISRAEL AUTO-INJECTORS MARKET SIZE, BY THERAPEUTIC USE, 2018-2030 (USD MILLION)
• TABLE 188. ISRAEL AUTO-INJECTORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 189. ITALY AUTO-INJECTORS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 190. ITALY AUTO-INJECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 191. ITALY AUTO-INJECTORS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 192. ITALY AUTO-INJECTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 193. ITALY AUTO-INJECTORS MARKET SIZE, BY THERAPEUTIC USE, 2018-2030 (USD MILLION)
• TABLE 194. ITALY AUTO-INJECTORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 195. NETHERLANDS AUTO-INJECTORS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 196. NETHERLANDS AUTO-INJECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 197. NETHERLANDS AUTO-INJECTORS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 198. NETHERLANDS AUTO-INJECTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 199. NETHERLANDS AUTO-INJECTORS MARKET SIZE, BY THERAPEUTIC USE, 2018-2030 (USD MILLION)
• TABLE 200. NETHERLANDS AUTO-INJECTORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 201. NIGERIA AUTO-INJECTORS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 202. NIGERIA AUTO-INJECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 203. NIGERIA AUTO-INJECTORS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 204. NIGERIA AUTO-INJECTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 205. NIGERIA AUTO-INJECTORS MARKET SIZE, BY THERAPEUTIC USE, 2018-2030 (USD MILLION)
• TABLE 206. NIGERIA AUTO-INJECTORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 207. NORWAY AUTO-INJECTORS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 208. NORWAY AUTO-INJECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 209. NORWAY AUTO-INJECTORS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 210. NORWAY AUTO-INJECTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 211. NORWAY AUTO-INJECTORS MARKET SIZE, BY THERAPEUTIC USE, 2018-2030 (USD MILLION)
• TABLE 212. NORWAY AUTO-INJECTORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 213. POLAND AUTO-INJECTORS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 214. POLAND AUTO-INJECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 215. POLAND AUTO-INJECTORS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 216. POLAND AUTO-INJECTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 217. POLAND AUTO-INJECTORS MARKET SIZE, BY THERAPEUTIC USE, 2018-2030 (USD MILLION)
• TABLE 218. POLAND AUTO-INJECTORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 219. QATAR AUTO-INJECTORS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 220. QATAR AUTO-INJECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 221. QATAR AUTO-INJECTORS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 222. QATAR AUTO-INJECTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 223. QATAR AUTO-INJECTORS MARKET SIZE, BY THERAPEUTIC USE, 2018-2030 (USD MILLION)
• TABLE 224. QATAR AUTO-INJECTORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 225. RUSSIA AUTO-INJECTORS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 226. RUSSIA AUTO-INJECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 227. RUSSIA AUTO-INJECTORS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 228. RUSSIA AUTO-INJECTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 229. RUSSIA AUTO-INJECTORS MARKET SIZE, BY THERAPEUTIC USE, 2018-2030 (USD MILLION)
• TABLE 230. RUSSIA AUTO-INJECTORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 231. SAUDI ARABIA AUTO-INJECTORS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 232. SAUDI ARABIA AUTO-INJECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 233. SAUDI ARABIA AUTO-INJECTORS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 234. SAUDI ARABIA AUTO-INJECTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 235. SAUDI ARABIA AUTO-INJECTORS MARKET SIZE, BY THERAPEUTIC USE, 2018-2030 (USD MILLION)
• TABLE 236. SAUDI ARABIA AUTO-INJECTORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 237. SOUTH AFRICA AUTO-INJECTORS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 238. SOUTH AFRICA AUTO-INJECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 239. SOUTH AFRICA AUTO-INJECTORS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 240. SOUTH AFRICA AUTO-INJECTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 241. SOUTH AFRICA AUTO-INJECTORS MARKET SIZE, BY THERAPEUTIC USE, 2018-2030 (USD MILLION)
• TABLE 242. SOUTH AFRICA AUTO-INJECTORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 243. SPAIN AUTO-INJECTORS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 244. SPAIN AUTO-INJECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 245. SPAIN AUTO-INJECTORS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 246. SPAIN AUTO-INJECTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 247. SPAIN AUTO-INJECTORS MARKET SIZE, BY THERAPEUTIC USE, 2018-2030 (USD MILLION)
• TABLE 248. SPAIN AUTO-INJECTORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 249. SWEDEN AUTO-INJECTORS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 250. SWEDEN AUTO-INJECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 251. SWEDEN AUTO-INJECTORS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 252. SWEDEN AUTO-INJECTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 253. SWEDEN AUTO-INJECTORS MARKET SIZE, BY THERAPEUTIC USE, 2018-2030 (USD MILLION)
• TABLE 254. SWEDEN AUTO-INJECTORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 255. SWITZERLAND AUTO-INJECTORS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 256. SWITZERLAND AUTO-INJECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 257. SWITZERLAND AUTO-INJECTORS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 258. SWITZERLAND AUTO-INJECTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 259. SWITZERLAND AUTO-INJECTORS MARKET SIZE, BY THERAPEUTIC USE, 2018-2030 (USD MILLION)
• TABLE 260. SWITZERLAND AUTO-INJECTORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 261. TURKEY AUTO-INJECTORS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 262. TURKEY AUTO-INJECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 263. TURKEY AUTO-INJECTORS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 264. TURKEY AUTO-INJECTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 265. TURKEY AUTO-INJECTORS MARKET SIZE, BY THERAPEUTIC USE, 2018-2030 (USD MILLION)
• TABLE 266. TURKEY AUTO-INJECTORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 267. UNITED ARAB EMIRATES AUTO-INJECTORS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 268. UNITED ARAB EMIRATES AUTO-INJECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 269. UNITED ARAB EMIRATES AUTO-INJECTORS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 270. UNITED ARAB EMIRATES AUTO-INJECTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 271. UNITED ARAB EMIRATES AUTO-INJECTORS MARKET SIZE, BY THERAPEUTIC USE, 2018-2030 (USD MILLION)
• TABLE 272. UNITED ARAB EMIRATES AUTO-INJECTORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 273. UNITED KINGDOM AUTO-INJECTORS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 274. UNITED KINGDOM AUTO-INJECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 275. UNITED KINGDOM AUTO-INJECTORS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 276. UNITED KINGDOM AUTO-INJECTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 277. UNITED KINGDOM AUTO-INJECTORS MARKET SIZE, BY THERAPEUTIC USE, 2018-2030 (USD MILLION)
• TABLE 278. UNITED KINGDOM AUTO-INJECTORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 279. AUTO-INJECTORS MARKET SHARE, BY KEY PLAYER, 2024
• TABLE 280. AUTO-INJECTORS MARKET, FPNV POSITIONING MATRIX, 2024

The Auto-Injectors Market was valued at USD 1.01 billion in 2024 and is projected to grow to USD 1.10 billion in 2025, with a CAGR of 9.22%, reaching USD 1.72 billion by 2030.

Auto-injectors have emerged as a pivotal technology in modern healthcare, transforming the administration of medications with precision, safety, and efficiency. This executive summary explores the evolution of auto-injectors and their growing significance across various therapeutic disciplines. Over recent years, rapid advancements in device engineering and biotechnology have elevated auto-injectors from simple delivery mechanisms to sophisticated tools that ensure better patient compliance and improved clinical outcomes. Technological innovations, coupled with an increasing demand for rapid and user-friendly drug administration, have spurred growth in both the development and adoption of these devices.

In this dynamic landscape, manufacturers continue to innovate by integrating features that enhance usability and reliability, thereby broadening the scope of treatment options available in both emergency and chronic care settings. The market not only benefits from these technological advances but also from a heightened focus on safety protocols and cost efficiency. As stakeholders from clinical, manufacturing, and regulatory spheres converge on the auto-injectors market, the industry is witnessing significant shifts in production standards, distribution strategies, and end-user integration.

This comprehensive overview provides insights that are essential for decision-makers and experts seeking to understand both the transformative trends and nuanced market dynamics driving growth in the auto-injectors domain.

Transformative Shifts in the Landscape: Embracing Change and Innovation

In recent years, the auto-injectors market has experienced transformative shifts driven by technological breakthroughs, evolving patient needs, and dynamic regulatory environments. Manufacturers have adopted cutting-edge materials and design methodologies that not only enhance device durability but also significantly improve user experience. As the healthcare ecosystem becomes more patient-centric, auto-injectors are increasingly engineered to provide rapid, reliable, and intuitive results during emergencies and routine treatments alike.

Market leaders are capitalizing on digital integration, incorporating smart features that enable real-time monitoring, data analytics, and connectivity with broader health management systems. This evolution is particularly evident in improved safety protocols and precise dosing mechanisms, which have garnered support from both clinical practitioners and end users. Concurrently, regulatory bodies are establishing more rigorous standards that encourage innovation while ensuring product safety, thus creating an environment where high-quality, next-generation auto-injectors can thrive.

These shifts are fueled by a growing emphasis on decentralizing healthcare delivery, where patients seek personalized and accessible care. The convergence of advanced sensor technologies with ergonomic design principles continues to drive enhancements in device performance. As traditional therapeutic models evolve, the adaptability and scalability of auto-injectors position them at the forefront of modern treatment paradigms, ultimately transforming patient engagement and outcomes.

Key Segmentation Insights: Understanding the Diverse Components of the Auto-Injectors Market

A detailed examination of the auto-injectors market reveals significant segmentation across several key dimensions, each contributing uniquely to the industry's overall growth and innovation. An insightful analysis based on components illustrates that the market is meticulously studied across the activation button, needle, pen cap, pre-loaded spring, and primary drug container. This approach enables a closer inspection of the product's mechanical intricacies and its evolution to accommodate enhanced performance and safety measures.

Further segmentation based on product type, distinguishing between disposable and reusable devices, sheds light on consumer preferences and lifecycle management. This distinction plays a crucial role in both pricing strategies and sustainability considerations within the sector. In addition, the differentiation by mode of administration-specifically intramuscular and subcutaneous-provides critical insights into the therapeutic adaptability of auto-injectors, aligning device functionality with clinical requirements.

Distribution channels also inform segmentation analysis, with offline and online retail frameworks highlighting shifts in consumer behavior and market access. When therapeutic use is recognized, the market is broken down into chronic treatment, emergency treatment, and preventive treatment segments, each demanding unique regulatory and formulation approaches. Finally, an evaluation based on end use differentiates between homecare settings and hospitals and clinics, underscoring the operational diversity that dictates the deployment and management of these devices. Collectively, these segmentation insights provide a granular understanding of market trends and support strategic decision-making for stakeholders aspiring to optimize product portfolios and market reach.

Based on Component, market is studied across Activation Button, Needle, Pen Cap, Pre-Loaded Spring, and Primary Drug Container.

Based on Type, market is studied across Disposable and Reusable.

Based on Mode of Administration, market is studied across Intramuscular and Subcutaneous.

Based on Distribution Channel, market is studied across Offline Retail and Online Retail.

Based on Therapeutic Use, market is studied across Chronic Treatment, Emergency Treatment, and Preventive Treatment.

Based on End Use, market is studied across Homecare Settings and Hospitals & Clinics.

Key Regional Insights: Geographic Dynamics Shaping the Auto-Injectors Market

The auto-injectors market exhibits distinct regional characteristics that influence both growth trajectories and competitive strategies. In the Americas, robust investments in healthcare infrastructure, coupled with a proactive regulatory framework, are driving the rapid adoption of auto-injectors in both emergency and chronic care scenarios. This region benefits from high-end technology integration and a strong emphasis on patient-centric solutions, ensuring that innovations translate effectively into clinical practice.

Across Europe, the Middle East, and Africa, stringent regulatory environments and a diverse demographic landscape foster a unique market scenario. This region is witnessing accelerated digital transformations, combined with increasing funding for research and development, which ultimately supports the adoption of advanced auto-injector technologies. These areas are also characterized by a balanced mix of public and private healthcare investments, which catalyze product standardization and increased market penetration.

In the rapidly expanding Asia-Pacific market, the surge in population dynamics, improvements in health literacy, and escalating healthcare expenditures actively contribute to a burgeoning demand for auto-injector devices. The region's growth is also propelled by innovative distribution networks and an increasing focus on preventive healthcare. These regional insights collectively underscore the importance of tailoring business strategies to meet localized demands and regulatory imperatives, ensuring that technological advancements align with broader regional healthcare outcomes.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Key Companies Insights: Leading Players Steering Market Evolution

The auto-injectors landscape is influenced by a spectrum of key industry players whose strategic initiatives and innovative product offerings continue to set benchmarks for excellence. Prominent organizations such as AbbVie Inc. and Amgen Inc. have consistently demonstrated a commitment to research and development, ensuring that their products remain at the cutting edge of technology. Companies like Aktiv Medical Systems and Amneal Pharmaceuticals, Inc. have also contributed significantly by refining product ergonomics and efficiency, making auto-injectors increasingly reliable for both emergency applications and ongoing therapies.

Major players including AptarGroup, Inc., Bayer AG, and Becton, Dickinson and Company have broadened their market presence by leveraging their extensive distribution networks and capitalizing on emerging market trends. The competitive landscape is further enriched by the contributions of Biogen Inc., Eli Lilly and Company, and Gerresheimer AG, each of which brings unique insights into process optimization and patient safety enhancements. Other influential corporations such as GlaxoSmithKline PLC and Halozyme Therapeutics, Inc. continue to push the envelope, pioneering novel approaches to drug delivery mechanisms.

Furthermore, industry giants like Johnson & Johnson Services, Inc., Medeca Pharma AB, and Merck KGaA are recognized for their strategic advancements in innovation and cross-functional collaborations. The progressive moves by Mylan N.V. by Viatris Inc., NEMERA Group, and Novartis AG have established benchmarks in market performance, while Pfizer, Inc., Ravimed Sp. z o.o., Recipharm AB, and Sanofi S.A. reinforce the importance of quality assurance and regulatory compliance. Emerging leaders including SHL Medical AG, Stevanato Group, Teva Pharmaceutical Industries Ltd., West Pharmaceutical Services, Inc., and Ypsomed Holding AG are rapidly carving out a niche for themselves, underscoring the dynamic and competitive nature of this market segment.

The report delves into recent significant developments in the Auto-Injectors Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Aktiv Medical Systems, Amgen Inc., Amneal Pharmaceuticals, Inc., AptarGroup, Inc., Bayer AG, Becton, Dickinson and Company, Biogen Inc., Eli Lilly and Company, Gerresheimer AG, GlaxoSmithKline PLC, Halozyme Therapeutics, Inc., Johnson & Johnson Services, Inc., Medeca Pharma AB, Merck KGaA, Mylan N.V. by Viatris Inc., NEMERA Group, Novartis AG, Pfizer, Inc., Ravimed Sp. z o.o., Recipharm AB, Sanofi S.A., SHL Medical AG, Stevanato Group, Teva Pharmaceutical Industries Ltd., West Pharmaceutical Services, Inc., and Ypsomed Holding AG. Actionable Recommendations for Industry Leaders: Strategies to Sustain Market Leadership

Industry leaders must adopt a multi-pronged approach to continue fostering innovation and maintaining a competitive edge in the auto-injectors market. Investment in research and development, particularly in the areas of device miniaturization, digital connectivity, and sustainability, is crucial. Companies are advised to enhance collaboration with academic institutions and research centers to foster technological breakthroughs and accelerate product refinement.

Additionally, adopting agile regulatory strategies that align with emerging standards and market expectations can facilitate smoother market entry and product launches. Cross-functional integration of insights from both clinical end-users and engineering teams allows for the design of user-friendly devices that ensure safety and efficacy. Embracing digital transformation through innovative digital marketing and e-commerce initiatives will further enhance market penetration and consumer engagement, ultimately driving profitability and brand loyalty.

Strategic partnerships, both domestic and international, can also play a pivotal role in expanding market reach and fostering local adaptability. By aligning operational strategies with evolving patient needs and technological opportunities, leaders can set a robust foundation for sustained success in a rapidly evolving market landscape.

Conclusion: Synthesizing Insights and Charting Future Trajectories

In summary, the auto-injectors market is undergoing significant transitions as technological innovations, rigorous regulatory frameworks, and evolving patient dynamics reshape the industry. The integration of advanced components and the focus on user-centric design have collectively propelled the market into a new era characterized by enhanced safety, precision, and operational efficiency. By delving deep into the segmentation based on product components, administration modes, and distribution channels, stakeholders are better equipped to navigate the competitive landscape.

Regional insights reveal a diversified market with distinct growth drivers in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific regions. Meanwhile, the strategic maneuvers of key industry players underscore the importance of constant innovation and quality assurance in securing market leadership. Overall, these insights coalesce to form a comprehensive picture of the industry's current state and future possibilities, providing a reliable roadmap for both established professionals and emerging market entrants.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing prevalence of chronic and lifestyle diseases globally
    • 5.1.1.2. Growing demand for at-home and emergency treatment solutions
  • 5.1.2. Restraints
    • 5.1.2.1. Stringent regulatory compliance and lengthy approval processes
  • 5.1.3. Opportunities
    • 5.1.3.1. Development of auto-injectors with integrated data analytics for personalized treatment approaches
    • 5.1.3.2. Expanding adoption of auto-injectors in sports medicine and emergency response scenarios
  • 5.1.4. Challenges
    • 5.1.4.1. Environmental concerns over disposal of auto-injectors
• 5.2. Market Segmentation Analysis
  • 5.2.1. Type: Increasing preference for disposable auto-injectors in emergency and acute care settings
  • 5.2.2. Therapeutic Use: Expanding utilization of auto-injectors in emergency treatment
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Auto-Injectors Market, by Component

• 6.1. Introduction
• 6.2. Activation Button
• 6.3. Needle
• 6.4. Pen Cap
• 6.5. Pre-Loaded Spring
• 6.6. Primary Drug Container

7. Auto-Injectors Market, by Type

• 7.1. Introduction
• 7.2. Disposable
• 7.3. Reusable

8. Auto-Injectors Market, by Mode of Administration

• 8.1. Introduction
• 8.2. Intramuscular
• 8.3. Subcutaneous

9. Auto-Injectors Market, by Distribution Channel

• 9.1. Introduction
• 9.2. Offline Retail
• 9.3. Online Retail

10. Auto-Injectors Market, by Therapeutic Use

• 10.1. Introduction
• 10.2. Chronic Treatment
• 10.3. Emergency Treatment
• 10.4. Preventive Treatment

11. Auto-Injectors Market, by End Use

• 11.1. Introduction
• 11.2. Homecare Settings
• 11.3. Hospitals & Clinics

12. Americas Auto-Injectors Market

• 12.1. Introduction
• 12.2. Argentina
• 12.3. Brazil
• 12.4. Canada
• 12.5. Mexico
• 12.6. United States

13. Asia-Pacific Auto-Injectors Market

• 13.1. Introduction
• 13.2. Australia
• 13.3. China
• 13.4. India
• 13.5. Indonesia
• 13.6. Japan
• 13.7. Malaysia
• 13.8. Philippines
• 13.9. Singapore
• 13.10. South Korea
• 13.11. Taiwan
• 13.12. Thailand
• 13.13. Vietnam

14. Europe, Middle East & Africa Auto-Injectors Market

• 14.1. Introduction
• 14.2. Denmark
• 14.3. Egypt
• 14.4. Finland
• 14.5. France
• 14.6. Germany
• 14.7. Israel
• 14.8. Italy
• 14.9. Netherlands
• 14.10. Nigeria
• 14.11. Norway
• 14.12. Poland
• 14.13. Qatar
• 14.14. Russia
• 14.15. Saudi Arabia
• 14.16. South Africa
• 14.17. Spain
• 14.18. Sweden
• 14.19. Switzerland
• 14.20. Turkey
• 14.21. United Arab Emirates
• 14.22. United Kingdom

15. Competitive Landscape

• 15.1. Market Share Analysis, 2024
• 15.2. FPNV Positioning Matrix, 2024
• 15.3. Competitive Scenario Analysis
  • 15.3.1. Aktiv Medical Systems partners with a global pharmaceutical company to innovate a high-concentration autoinjector solution using its PenPal platform
  • 15.3.2. Nemera launches a reusable auto-injector platform at CPHI Milan to improve patient adherence and accelerate time-to-market in parenteral drug delivery
  • 15.3.3. FDA approval of Zurnai nalmefene auto-injector advances rapid emergency responses and harm reduction strategies
• 15.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. AbbVie Inc.
• 2. Aktiv Medical Systems
• 3. Amgen Inc.
• 4. Amneal Pharmaceuticals, Inc.
• 5. AptarGroup, Inc.
• 6. Bayer AG
• 7. Becton, Dickinson and Company
• 8. Biogen Inc.
• 9. Eli Lilly and Company
• 10. Gerresheimer AG
• 11. GlaxoSmithKline PLC
• 12. Halozyme Therapeutics, Inc.
• 13. Johnson & Johnson Services, Inc.
• 14. Medeca Pharma AB
• 15. Merck KGaA
• 16. Mylan N.V. by Viatris Inc.
• 17. NEMERA Group
• 18. Novartis AG
• 19. Pfizer, Inc.
• 20. Ravimed Sp. z o.o.
• 21. Recipharm AB
• 22. Sanofi S.A.
• 23. SHL Medical AG
• 24. Stevanato Group
• 25. Teva Pharmaceutical Industries Ltd.
• 26. West Pharmaceutical Services, Inc.
• 27. Ypsomed Holding AG